MedPath

TEVA-RISPERIDONE

TEVA-RISPERIDONE

Approved
DIN Number

02264226

Drug Class

Human

Market Date

Jul 5, 2006

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02264226
AIG Number0124332002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AX08 RISPERIDONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

RISPERIDONEActive
Strength: 3 MG
Monograph: RISPERIDONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.